The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth.
Viskin
Sami
S
Rosovski
Uri
U
D000083:Acetanilides; D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D026902:Potassium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D000069458:Ranolazine; D012107:Research Design; D016171:Torsades de Pointes / Q000139:chemically induced*; D014700:Verapamil / Q000009:adverse effects / Q000627:therapeutic use
D000083:Acetanilides; D000889:Anti-Arrhythmia Agents; D010879:Piperazines; D026902:Potassium Channel Blockers; D000069458:Ranolazine; D014700:Verapamil; D000638:Amiodarone